Latest News

CrowdStrike's business is growing fast, but at a $264 billion valuation, the price investors pay matters as much as the growth.

The housing market has hit a wall, which is a problem for housing-related stocks, but Lowe's may have a valuation edge over Home Depot.

A mortgage REIT is basically worth what its portfolio of mortgage securities is worth.

Incyte (NASDAQ:INCY) presented updated clinical data and development plans for two experimental solid-tumor programs at ESMO in Madrid: INCA33890, a TGFβR2-by-PD-1 bispecific antibody known as “’890,” and INCB161734, a KRAS G12D-targeted small molecule known as “’734.” The company said both program

The social media company is growing its monthly active users in its most lucrative region.

Nvidia and Meta are two of my favorite stocks, but only one can be the better investment in this head-to-head comparison.

It's not worth owning Costco just for the dividend, but it's still an investable opportunity with plenty of upside potential.

These Canadian dividend stocks could help late starters build retirement savings through income and long-term growth.

Does Nike represent a value opportunity or value trap?

Retirement savings can last longer with proper fund management, a well-structured withdrawal strategy, and controlled spending.

Business is booming for SpaceX.

The leading cryptocurrency has outperformed all major asset classes over the last 10 years, and JPMorgan Chase expects the same over the next 10.

Google Cloud's profits are real, but Alphabet's Oct. 28 report needs to show those profits turning into cash before investors stop footing the bill for its $200 billion AI build-out.

SpaceX, Nvidia, and Alphabet are all likely to be worth more than Apple by the end of 2031.

eBay has been one of my better stock picks of 2026.

Don't touch TELUS stock until you evaluate these items in its upcoming quarterly report in November.

Elevra Lithium (NASDAQ:ELVR) reported a stronger start to fiscal 2027, driven by record mining and milling activity at its North American Lithium operation, higher concentrate sales and lower unit costs. The company also said its NAL expansion has entered execution, while it continues to streamline

Astrazeneca (NYSE:AZN) highlighted new clinical data across bladder, lung and gastric cancers at its ESMO 2026 investor event, including four presidential presentations that executives said support the company’s oncology growth strategy. Dave Fredrickson, executive vice president of the company’s o

Investments in driverless technology and robotics are causing Tesla's profits to crash.

Recent pullbacks in these top TSX stocks have pushed up their dividend yields.

Agentic AI could be a boon for the chipmaker.

Thankfully, I warned investors dozens of times to avoid this EV charging company.

Nebius is one of the fastest-growing AI companies on the planet.

Anthropic faces hundreds of billions in cloud commitments.

Revenue growth is accelerating, but at the expense of operating profit margins.